2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions

View by Date

Monday, June 4, 2018

5:30pm-5:42pm: Improved OPO Performance Drives Broader Organ Sharing in the United States

R. Carrico, B. Shepard, D. Klassen.

Concurrent Session: Non-Organ Specific: Economics, Public Policy, Allocation, Ethics - 1 • Room 4C-4

5:30pm-5:42pm: Information Needs of Adolescent Transplant Recipients Transitioning to Adult Care

B. Kosmach-Park,¹ D. Shellmer,² C. Nguyen,³ G. Mazariegos.²

Concurrent Session: Psychosocial and Treatment Adherence • Room 3AB

5:30pm-5:42pm: Lab Turnaround Times: A Performance Improvement Project in Post Kidney/Pancreas Transplant Clinic

M. Farrell, S. Kapadia.

Concurrent Session: Regulatory Issues • Room 2AB

5:30pm-5:42pm: Long-Term Kidney Transplant Survival after Deceased-Donor Acute Kidney Injury

I. Hall, E. Akalin, J. Bromberg, M. Doshi, M. Harhay, Y. Jia, S. Mansour, S. Mohan, T. Muthumkumar, P. Reese, B. Schröppel, P. Singh, H. Thiessen-Philbrook, F. Weng, C. Parikh.

Concurrent Session: Kidney Complications: Late Graft Failure • Room 6E

5:30pm-5:42pm: Novel Vascular Inflow Offers Renal Transplantation to Recipients with Severe Central and Peripheral Vascular Disease

S. Mao,¹ E. Giorgakis,² A. Moss,² T. Taner.¹

Concurrent Session: Kidney: Surgical Considerations • Room 210

5:30pm-5:42pm: Pancreas Transplant in the Elderly Patient – Should It Be Done?

A. Gruessner,¹ M. Laftavi,² O. Pankewycz,² R. Gruessner.¹

Concurrent Session: Pancreas and Islet - 1 • Room 4C-3

5:30pm-5:42pm: Post‐Donation eGFR Levels Predicts New‐Onset Antihypertensive Medication Use after Living Kidney Donation

K. Lentine,¹ D. Segev,² N. Lam,³ A. Garg,⁴ A. Naik,⁵ D. Axelrod,⁶ H. Xiao,¹ M. Henderson,² A. Massie,² B. Kasiske,⁷ G. Hess,⁸ C. Hsu,⁹ D. Brennan,² M. Schnitzler.¹

Concurrent Session: Kidney Living Donor: Long Term Outcomes • Room 6A

5:30pm-5:42pm: Preformed Donor-Reactive T-Cells That Persist after ABO Desensitization Independently Predict Severe Acute Cellular Rejection after Living Donor Kidney Transplantation

T. Schachtner,^1,2,3 M. Stein,² P. Reinke.^1,2

Concurrent Session: Kidney Immunosuppression: Desensitization • Room 4B

5:30pm-5:42pm: Rapamycin Impairs Human Endothelial Cell Alloimmunogenicity Independent of PD-1/PD-1 Ligand Inhibitory Signaling

Q. Gao, V. Bendersky, A. Kirk, H. Xu.

Concurrent Session: Endothelial Cell Biology • Room 615/616/617

5:30pm-5:42pm: Should More Donation after Cardiac Death Livers Be Used in Pediatric Transplantation?

C. Hwang,¹ S. Levea,² M. MacConmara.¹

Concurrent Session: Liver: Pediatrics • Room 608/609